Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular disease BOSTON–(BUSINESS WIRE)–Clairity, Inc., an AI-driven precision health company pioneering image-based risk prediction, today announced…
